We use cookies to improve your experience. By continuing to browse this site, you accept our cookie policy.×
Skip main navigation
Aging Health
Bioelectronics in Medicine
Biomarkers in Medicine
Breast Cancer Management
CNS Oncology
Colorectal Cancer
Concussion
Epigenomics
Future Cardiology
Future Medicine AI
Future Microbiology
Future Neurology
Future Oncology
Future Rare Diseases
Future Virology
Hepatic Oncology
HIV Therapy
Immunotherapy
International Journal of Endocrine Oncology
International Journal of Hematologic Oncology
Journal of 3D Printing in Medicine
Lung Cancer Management
Melanoma Management
Nanomedicine
Neurodegenerative Disease Management
Pain Management
Pediatric Health
Personalized Medicine
Pharmacogenomics
Regenerative Medicine

Exercise and heart disease: from athletes and arrhythmias to hypertrophic cardiomyopathy and congenital heart disease

    Abbas Zaidi

    Department of Cardiovascular Sciences, St George’s, University of London, Cranmer Terrace, London SW17 0RE, UK

    &
    Sanjay Sharma

    * Author for correspondence

    Department of Cardiovascular Sciences, St George’s, University of London, Cranmer Terrace, London SW17 0RE, UK.

    Published Online:https://doi.org/10.2217/fca.12.81

    The beneficial effects of regular physical activity on cardiovascular health are well established, with convincing evidence of improvements in blood pressure, lipid profile and overall mortality. Conversely, individuals with pre-existing congenital, inherited or acquired heart conditions may experience functional cardiac deterioration or sudden death during even moderate exertion. Exclusion from high-level sporting activity may be mandated in some cases, and pre-participation screening of competitive athletes plays an important role in the identification of such individuals. The issue of screening is complicated by the fact that physiological cardiovascular adaptation in healthy athletes, including modest left ventricular hypertrophy and biventricular cavity dilatation, may create a diagnostic overlap with pathological conditions such as hypertrophic cardiomyopathy. Furthermore, much interest has focused recently on the possibility of irreversible cardiac remodeling in a proportion of veteran endurance athletes, with the potential for arrhythmogenesis and adverse cardiac events.

    Papers of special note have been highlighted as: ▪ of interest ▪▪ of considerable interest

    References

    • Ohta M, Tajiri Y, Yamato H, Ikeda M. Effects of exercise therapy alone and in combination with a calcium channel blocker or an angiotensin receptor blocker in hypertensive patients. Clin. Exp. Hypertens. doi:10.3109/10641963.2012.681722 (2012) (Epub ahead of print).
    • Walker KZ, Piers LS, Putt RS, Jones JA, O’Dea K. Effects of regular walking on cardiovascular risk factors and body composition in normoglycemic women and women with Type 2 diabetes. Diabetes Care22,555–561 (1999).
    • Heydari M, Freund J, Boutcher SH. The effect of high-intensity intermittent exercise on body composition of overweight young males. J. Obes.2012,480467 (2012).
    • Sarna S, Sahi T, Koskenvuo M, Kaprio J. Increased life expectancy of world class male athletes. Med. Sci. Sports Exerc.25,237–244 (1993).
    • Tanasescu M, Leitzmann M, Rimm EB, Willett WC, Stampfer MJ, Hu FB. Exercise type and intensity in relation to coronary heart disease in men. JAMA288,1994–2000 (2002).▪ Frequently quoted study demonstrating the incremental cardiac health benefits of regular physical activity.
    • Corrado D, Basso C, Rizzoli G, Schiavon M, Thiene G. Does sport activity enhance the risk of sudden death in adolescents and young adults? J. Am. Coll. Cardiol.42,1959–1963 (2003).
    • Maron BJ, Gohman TE, Aeppli D. Prevalence of sudden cardiac death during competitive sports activities in Minnesota highschool athletes. J. Am. Coll. Cardiol.32,1881–1884 (1998).
    • Drezner JA, Rao AL, Heistand J et al. Effectiveness of emergency response planning for sudden cardiac arrest in United States high schools with automated external defibrillators. Circulation120,518–525 (2009).
    • Drezner JA, Courson RW, Roberts WO et al. Inter-association task force recommendations on emergency preparedness and management of sudden cardiac arrest in high school and college athletic programs: a consensus statement. Heart Rhythm4,549–565 (2007).
    • 10  Maron BJ, Thompson PD, Ackerman MJ et al. Recommendations and considerations related to preparticipation screening for cardiovascular abnormalities in competitive athletes: 2007 update. Circulation115,1643–1655 (2007).
    • 11  Corrado D, Basso C, Pavei A, Michieli P, Schiavon M, Thiene G. Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program. JAMA296,1593–1601 (2006).▪▪ Seminal study that forms the basis of the Italian model for screening young athletes.
    • 12  Corrado D, Basso C, Schiavon M, Thiene G. Screening for hypertrophic cardiomyopathy in young athletes. N. Engl. J. Med.339,364–369 (1998).
    • 13  Corrado D, Pelliccia A, Bjornstad H et al. Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol. Eur. Heart J.26,516–524 (2005).
    • 14  Wilson MG, Basavarajaiah S, Whyte GP, Cox S, Loose more M, Sharma S. Efficacy of personal symptom and family history questionnaires when screening for inherited cardiac pathologies: the role of electrocardiography. Br. J. Sports Med.42,207–211 (2008).
    • 15  Wheeler M, Heidenreich P, Froelicher V, Hlatky M, Ashley E. Cost–effectiveness of preparticipation screening for prevention ofsudden cardiac death in young athletes. Ann. Intern. Med.152,276–286 (2010).
    • 16  Pelliccia A, Maron BJ, Culasso F et al. Clinical significance of abnormal electrocardiographic patterns in trained athletes. Circulation102,278–284 (2000).
    • 17  Kim JH, Malhotra R, Chiampas G et al. Cardiac arrest during long-distance running races. N. Engl. J. Med.366,130–140 (2012).
    • 18  Tunstall Pedoe DS. Marathon cardiac deaths: the London experience. Sports Med.37,448–450 (2007).
    • 19  Borjesson M, Urhausen A, Kouidi E et al. Cardiovascular evaluation of middle-aged/senior individuals engaged in leisure-time sport activities: position stand from the sections of exercise physiology and sports cardiology of the European Association of Cardiovascular Prevention and Rehabilitation. Eur. J. Cardiovasc. Prev. Rehabil.18,446–458 (2011).
    • 20  Maron BJ, Zipes DP. 36th Bethesda conference: eligibility recommendations for competitive athletes with cardiovascular abnormalities. J. Am. Coll. Cardiol.45,1313–1375 (2005).
    • 21  Pelliccia A, Fagard R, Bjørnstad HH et al. Recommendations for competitive sports participation in athletes with cardiovascular disease. Eur. Heart J.26,1422–1445 (2005).
    • 22  Mitchell J, Haskell WL, Raven PB. Classification of sports. J. Am. Coll. Cardiol.24,864–866 (1994).
    • 23  Heidbüchel H, Corrado D, Biffi A et al. Recommendations for participation in leisure-time physical activity and competitive sports in patients with arrhythmias and potentially arrhythmogenic conditions Part II: ventricular arrhythmias, channelopathies and implantable defibrillators. Eur. J. Cardiovasc. Prev. Rehabil.13,676–686 (2006).
    • 24  Heidbüchel H, Corrado D, Biffi A et al. Recommendations for participation in leisure-time physical activity and competitive sports in patients with arrhythmias and potentially arrhythmogenic conditions Part I: supraventricular arrhythmias and pacemakers. Eur. J. Cardiovasc. Prev. Rehabil.13,475–484 (2006).
    • 25  Pelliccia A, Corrado D, Bjørnstad HH et al. Recommendations for participation in competitive sport and leisure-time physical activity in individuals with cardiomyopathies, myocarditis and pericarditis. Eur. J. Cardiovasc. Prev. Rehabil.13,876–885 (2006).
    • 26  Maron BJ, Chaitman BR, Ackerman MJ et al. Recommendations for physical activity and recreational sports participation for young patients with genetic cardiovascular diseases. Circulation109,2807–2816 (2004).
    • 27  Lawler PR, Filion KB, Eisenberg MJ. Efficacy of exercise-based cardiac rehabilitation post-myocardial infarction: a systematic review and meta-analysis of randomized controlled trials. Am. Heart J.162,571–584 (2011).
    • 28  Giannuzzi P, Mezzani A, Saner H et al. Physical activity for primary and secondary prevention. Position paper of the working group on cardiac rehabilitation and exercise physiology of the European society of cardiology. Eur. J. Cardiovasc. Prev. Rehabil.10,319–327 (2003).
    • 29  Corrado D, Pelliccia A, Heidbuchel H et al. Recommendations for interpretation of 12-lead electrocardiogram in the athlete. Eur. Heart J.31,243–259 (2010).▪▪ Describes and categorizes the important electrocardiographic anomalies evident in athletes.
    • 30  Magalski A, Maron BJ, Main ML et al. Relation of race to electrocardiographic patterns in elite American football players. J. Am. Coll. Cardiol.51,2250–2255 (2008).
    • 31  Basavarajaiah S, Boraita A, Whyte G et al. Ethnic differences in left ventricular remodeling in highly-trained athletes: relevance to differentiating physiologic left ventricular hypertrophy from hypertrophic cardiomyopathy. J. Am. Coll. Cardiol.51,2256–2262 (2008).▪▪ The first large-scale study to define ethnicity-based reference limits for cardiac remodeling in athletes.
    • 32  Papadakis M, Carre F, Kervio G et al. The prevalence, distribution, and clinical outcomes of electrocardiographic repolarization patterns in male athletes of African/Afro–Caribbean origin. Eur. Heart J.32,2304–2313 (2011).
    • 33  Luijkx T, Cramer MJ, Prakken NH et al. Sport category is an important determinant of cardiac adaptation: an MRI study. Br. J. Sports. Med. doi: 10.1136/bjsports-2011-090520 (2012) (Epub ahead of print).
    • 34  Lang RM, Bierig M, Devereux RB. Recommendations for chamber quantification. Eur. J. Echocardiogr.7,79–108 (2006).
    • 35  Pelliccia A, Maron BJ, Spataro A, Proschan MA, Spirito P. The upper limit of physiologic cardiac hypertrophy in highly trained elite athletes. N. Engl. J. Med.324,295–301 (1991).▪ Landmark study demonstrating the effects of regular exercise on left ventricular dimensions.
    • 36  Pelliccia A, Culasso F, Di Paolo F, Maron BJ. Physiologic left ventricular cavity dilatation in elite athletes. Ann. Intern. Med.130,23–31 (1999).
    • 37  Pelliccia A, Maron BJ, Culasso F, Spataro A, Caselli G. Athlete’s heart in women. Echocardiographic characterization of highly trained elite female athletes. JAMA276,211–215 (1996).
    • 38  Makan J, Sharma S, Firoozi S, Whyte G, Jackson PG, McKenna WJ. Physiological upper limits of ventricular cavity size in highly trained adolescent athletes. Heart91,495–499 (2005).
    • 39  Sharma S, Maron BJ, Whyte G, Firoozi S, Elliott PM, McKenna WJ. Physiologic limits of left ventricular hypertrophy in elite junior athletes: relevance to differential diagnosis of athlete’s heart from hypertrophic cardiomyopathy. J. Am. Coll. Cardiol.40,1431–1436 (2002).
    • 40  Spirito P, Pelliccia A, Proschan MA et al. Morphology of the ‘athlete’s heart’ assessed by echocardiography in 947 elite athletes representing 27 sports. Am. J. Cardiol.74,802–806 (1994).
    • 41  D’Andrea A, Riegler L, Golia E et al. Range of right heart measurements in top-level athletes: the training impact. Int. J. Cardiol. doi:10.1016/j.ijcard.2011.06.058 (2011) (Epub ahead of print).
    • 42  Rawlins J, Carre F, Kervio G et al. Ethnic differences in physiological cardiac adaptation to intense physical exercise in highly trained female athletes. Circulation121,1078–1085 (2010).
    • 43  Bauce B, Frigo G, Benini G et al. Differences and similarities between arrhythmogenic right ventricular cardiomyopathy and athlete’s heart adaptations. Br. J. Sports Med.44,148–154 (2010).
    • 44  Cox MG, Nelen MR, Wilde AA et al. Activation delay and VT parameters in arrhythmogenic right ventricular dysplasia/cardiomyopathy: toward improvement of diagnostic ECG criteria. J. Cardiovasc. Electrophysiol.19,775–781 (2008).
    • 45  Marcus FI, McKenna WJ, Sherrill D et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D): proposed modification of the task force criteria. Circulation121,1533–1541 (2010).
    • 46  Cavalcante JL, Barboza JS, Lever HM. Diversity of mitral valve abnormalities in obstructive hypertrophic cardiomyopathy. Prog. Cardiovasc. Dis.54,517–522 (2012).
    • 47  Luijkx T, Velthuis BK, Prakken NH et al. Impact of revised task force criteria: distinguishing the athlete’s heart from ARVC/D using cardiac magnetic resonance imaging. Eur. J. Cardiovasc. Prev. Rehabil.19(4),885–891 (2011).
    • 48  Teske AJ, Cox MG, De Boeck BW et al. Echocardiographic tissue deformation imaging quantifies abnormal regional right ventricular function in arrhythmogenic right ventricular dysplasia/cardiomyopathy. J. Am. Soc. Echocardiogr.22,920–927 (2009).
    • 49  Teske AJ, Prakken NH, De Boeck BW et al. Echocardiographic tissue deformation imaging of right ventricular systolic function in endurance athletes. Eur. Heart J.30,969–977 (2009).
    • 50  O’Hanlon R, Grasso A, Roughton M et al. Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy. J. Am. Coll. Cardiol.56,867–874 (2010).
    • 51  Petersen SE, Jerosch-Herold M, Hudsmith LE et al. Evidence for microvascular dysfunction in hypertrophic cardiomyopathy: new insights from multiparametric magnetic resonance imaging. Circulation115,2418–2425 (2007).
    • 52  Kawasaki T, Azuma A, Kuribayashi T et al. Vagal enhancement due to subendocardial ischemia as a cause of abnormal blood pressure response in hypertrophic cardiomyopathy. Int. J. Cardiol.129,59–64 (2008).
    • 53  Sharma S, Elliott PM, Whyte G et al. Utility of metabolicexercise testing in distinguishing hypertrophic cardiomyopathyfrom physiologic left ventricular hypertrophy in athletes. J. Am. Coll. Cardiol.36,864–870 (2000).
    • 54  Basavarajaiah S, Wilson M, Junagde S, Jackson G, Whyte G, Sharma S. Physiological left ventricular hypertrophy or hypertrophic cardiomyopathy in an elite adolescent athlete: role of detraining in resolving the clinical dilemma. Br. J. Sports Med.8,727–729 (2006).
    • 55  Hershberger RE, Lindenfeld J, Mestroni L, Seidman CE, Taylor MR, Towbin JA. Genetic evaluation of cardiomyopathy – a heart failure society of America practice guideline. J. Cardiac Fail.15,83–97 (2009).
    • 56  Oxborough D, Whyte G, Wilson MJ et al. A depression in left ventricular diastolic filling following prolonged strenuous exercise is associated with changes in left atrial mechanics. J. Am. Soc. Echocardiogr.23,968–976 (2010).
    • 57  Shave R, Baggish A, George K et al. Exercise-induced cardiac troponin elevation: evidence, mechanisms, and implications. J. Am. Coll. Cardiol.56,169–176 (2010).
    • 58  O’Hanlon R, Wilson M, Wage R et al. Troponin release following endurance exercise: is inflammation the cause? A cardiovascular magnetic resonance study. J. Cardiovasc. Magn. Reson.12,38 (2010).
    • 59  Whyte G, Sheppard M, George K et al. Post-mortem evidence of idiopathic left ventricular hypertrophy and idiopathic interstitial myocardial fibrosis: is exercise the cause? Br. J. Sports Med.42,304–305 (2008).
    • 60  Pelliccia A, Maron BJ, De Luca R, Di Paolo FM, Spataro A, Culasso F. Remodeling of left ventricular hypertrophy in elite athletes after long-term deconditioning. Circulation105,944–949 (2002).
    • 61  Mont L, Elosua R, Brugada J. Endurance sport practice as a risk factor for atrial fibrillation and atrial flutter. Europace11,11–17 (2009).
    • 62  Baldesberger S, Bauersfield U, Candinas R et al. Sinus node disease and arrhythmias in long-term follow-up of former professional cyclists. Eur. Heart J.29,71–78 (2008).
    • 63  Biffi A, Maron BJ, Verdile L et al. Impact of physical deconditioning on ventricular tachyarrhythmias in trained athletes. J. Am. Coll. Cardiol.44,1053–1058 (2004).
    • 64  La Gerche A, Heidbüchel H, Burns AT et al. Disproportionate exercise load and remodeling of the athlete’s right ventricle. Med. Sci. Sports Exerc.43,974–981 (2011).
    • 65  La Gerche A, Burns AT, Mooney DJ et al. Exercise-induced right ventricular dysfunction and structural remodeling in endurance athletes. Eur. Heart J.33,998–1006 (2012).▪▪ Recent paper furthering the notion that chronic endurance exercise may lead to irreversible cardiac damage.
    • 66  Heidbuchel H, Hoogsteen J, Fagard R et al. High prevalence of right ventricular involvement in endurance athletes with ventricular arrhythmias. Role of an electrophysiologic study in risk stratification. Eur. Heart J.24,1473–1480 (2003).
    • 67  Ector J, Ganame J, van der Merwe N et al. Reduced right ventricular ejection fraction in endurance athletes presenting with ventricular arrhythmias: a quantitative angiographic assessment. Eur. Heart J.28,345–353 (2007).
    • 68  La Gerche A, Robberecht C, Kuiperi C et al. Lower than expected desmosomal gene mutation prevalence in endurance athletes with complex ventricular arrhythmias of right ventricular origin. Heart96,1268–1274 (2010).
    • 69  Benito B, Gay-Jordi G, Serrano-Mollar A et al. Cardiac arrhythmogenic remodeling in a rat model of long-term intensive exercise training. Circulation123,13–22 (2011).
    • 70  Kirchhof P, Fabritz L, Zwiener M et al. Age- and training-dependent development of arrhythmogenic right ventricular cardiomyopathy in heterozygous plakoglobin-deficient mice. Circulation114,1799–1806 (2006).▪ Demonstrates the potential role of exercise in promoting an arrhythmogenic substrate in genetically predisposed individuals.
    • 71  Fabritz L, Hoogendijk MG, Scicluna BP et al. Load-reducing therapy prevents development of arrhythmogenic right ventricular cardiomyopathy in plakoglobin-deficient mice. J. Am. Coll. Cardiol.57,740–750 (2011).
    • 72  Rudski LG, Lai WW, Afilalo et al. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography. J. Am. Soc. Echocardiogr.23,685–713 (2010).
    • 73  Sharma S, Zaidi A. Exercise-induced arrhythmogenic rightventricular cardiomyopathy: fact or fallacy? Eur. Heart J.33,938–940 (2012).